 | • レポートコード：QFJ1-4081 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、皮膚肥満細胞症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗ヒスタミン薬、コルチコステロイド、肥満細胞安定剤、交感神経刺激薬（エフィネフリン）、光線化学療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・皮膚肥満細胞症治療の市場動向 ・企業の競争状況、市場シェア ・皮膚肥満細胞症治療の種類別市場規模と予測2016-2027（抗ヒスタミン薬、コルチコステロイド、肥満細胞安定剤、交感神経刺激薬（エフィネフリン）、光線化学療法） ・皮膚肥満細胞症治療の用途別市場規模と予測2016-2027（病院、診療所、その他） ・皮膚肥満細胞症治療の北米市場規模2016-2027（アメリカ、カナダ） ・皮膚肥満細胞症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・皮膚肥満細胞症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・皮膚肥満細胞症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・皮膚肥満細胞症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis AG、Mylan NV、Teva Pharmaceutical Industries Ltd.、Bausch Health Companies Inc.、Pfizer Inc.、Teva Pharmaceutical Industries Ltd.、Sanofi S.A.、Johnson & Johnson、Bayer AG、Mallinckrodt Pharmaceuticals） ・結論 |
Cutaneous mastocytosis is a form of mastocytosis that primarily affects the skin. There are three main forms of the condition: maculopapular cutaneous mastocytosis (also called urticaria pigmentosa), solitary cutaneous mastocytoma, and diffuse cutaneous mastocytosis.
Market Analysis and Insights: Global Cutaneous Mastocytosis Treatment Market
The global Cutaneous Mastocytosis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cutaneous Mastocytosis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cutaneous Mastocytosis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cutaneous Mastocytosis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cutaneous Mastocytosis Treatment market.
Global Cutaneous Mastocytosis Treatment Scope and Market Size
Cutaneous Mastocytosis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cutaneous Mastocytosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Antihistamines
Corticosteroids
Mast Cell Stabilizers
Sympathomimetic Agents (Ephinephrine)
Photochemotherapy
Segment by Application
Hospitals
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Novartis AG
Mylan NV
Teva Pharmaceutical Industries Ltd.
Bausch Health Companies Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Johnson & Johnson
Bayer AG
Mallinckrodt Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cutaneous Mastocytosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antihistamines
1.2.3 Corticosteroids
1.2.4 Mast Cell Stabilizers
1.2.5 Sympathomimetic Agents (Ephinephrine)
1.2.6 Photochemotherapy
1.3 Market by Application
1.3.1 Global Cutaneous Mastocytosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cutaneous Mastocytosis Treatment Market Perspective (2016-2027)
2.2 Cutaneous Mastocytosis Treatment Growth Trends by Regions
2.2.1 Cutaneous Mastocytosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cutaneous Mastocytosis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Cutaneous Mastocytosis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Cutaneous Mastocytosis Treatment Industry Dynamic
2.3.1 Cutaneous Mastocytosis Treatment Market Trends
2.3.2 Cutaneous Mastocytosis Treatment Market Drivers
2.3.3 Cutaneous Mastocytosis Treatment Market Challenges
2.3.4 Cutaneous Mastocytosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cutaneous Mastocytosis Treatment Players by Revenue
3.1.1 Global Top Cutaneous Mastocytosis Treatment Players by Revenue (2016-2021)
3.1.2 Global Cutaneous Mastocytosis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Cutaneous Mastocytosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cutaneous Mastocytosis Treatment Revenue
3.4 Global Cutaneous Mastocytosis Treatment Market Concentration Ratio
3.4.1 Global Cutaneous Mastocytosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cutaneous Mastocytosis Treatment Revenue in 2020
3.5 Cutaneous Mastocytosis Treatment Key Players Head office and Area Served
3.6 Key Players Cutaneous Mastocytosis Treatment Product Solution and Service
3.7 Date of Enter into Cutaneous Mastocytosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cutaneous Mastocytosis Treatment Breakdown Data by Type
4.1 Global Cutaneous Mastocytosis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Cutaneous Mastocytosis Treatment Forecasted Market Size by Type (2022-2027)
5 Cutaneous Mastocytosis Treatment Breakdown Data by Application
5.1 Global Cutaneous Mastocytosis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Cutaneous Mastocytosis Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cutaneous Mastocytosis Treatment Market Size (2016-2027)
6.2 North America Cutaneous Mastocytosis Treatment Market Size by Type
6.2.1 North America Cutaneous Mastocytosis Treatment Market Size by Type (2016-2021)
6.2.2 North America Cutaneous Mastocytosis Treatment Market Size by Type (2022-2027)
6.2.3 North America Cutaneous Mastocytosis Treatment Market Size by Type (2016-2027)
6.3 North America Cutaneous Mastocytosis Treatment Market Size by Application
6.3.1 North America Cutaneous Mastocytosis Treatment Market Size by Application (2016-2021)
6.3.2 North America Cutaneous Mastocytosis Treatment Market Size by Application (2022-2027)
6.3.3 North America Cutaneous Mastocytosis Treatment Market Size by Application (2016-2027)
6.4 North America Cutaneous Mastocytosis Treatment Market Size by Country
6.4.1 North America Cutaneous Mastocytosis Treatment Market Size by Country (2016-2021)
6.4.2 North America Cutaneous Mastocytosis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cutaneous Mastocytosis Treatment Market Size (2016-2027)
7.2 Europe Cutaneous Mastocytosis Treatment Market Size by Type
7.2.1 Europe Cutaneous Mastocytosis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Cutaneous Mastocytosis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Cutaneous Mastocytosis Treatment Market Size by Type (2016-2027)
7.3 Europe Cutaneous Mastocytosis Treatment Market Size by Application
7.3.1 Europe Cutaneous Mastocytosis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Cutaneous Mastocytosis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Cutaneous Mastocytosis Treatment Market Size by Application (2016-2027)
7.4 Europe Cutaneous Mastocytosis Treatment Market Size by Country
7.4.1 Europe Cutaneous Mastocytosis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Cutaneous Mastocytosis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cutaneous Mastocytosis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Cutaneous Mastocytosis Treatment Market Size by Type
8.2.1 Asia-Pacific Cutaneous Mastocytosis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cutaneous Mastocytosis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cutaneous Mastocytosis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Cutaneous Mastocytosis Treatment Market Size by Application
8.3.1 Asia-Pacific Cutaneous Mastocytosis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cutaneous Mastocytosis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cutaneous Mastocytosis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Cutaneous Mastocytosis Treatment Market Size by Region
8.4.1 Asia-Pacific Cutaneous Mastocytosis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cutaneous Mastocytosis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cutaneous Mastocytosis Treatment Market Size (2016-2027)
9.2 Latin America Cutaneous Mastocytosis Treatment Market Size by Type
9.2.1 Latin America Cutaneous Mastocytosis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Cutaneous Mastocytosis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Cutaneous Mastocytosis Treatment Market Size by Type (2016-2027)
9.3 Latin America Cutaneous Mastocytosis Treatment Market Size by Application
9.3.1 Latin America Cutaneous Mastocytosis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Cutaneous Mastocytosis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Cutaneous Mastocytosis Treatment Market Size by Application (2016-2027)
9.4 Latin America Cutaneous Mastocytosis Treatment Market Size by Country
9.4.1 Latin America Cutaneous Mastocytosis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Cutaneous Mastocytosis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cutaneous Mastocytosis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Cutaneous Mastocytosis Treatment Market Size by Type
10.2.1 Middle East & Africa Cutaneous Mastocytosis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cutaneous Mastocytosis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cutaneous Mastocytosis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Cutaneous Mastocytosis Treatment Market Size by Application
10.3.1 Middle East & Africa Cutaneous Mastocytosis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cutaneous Mastocytosis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cutaneous Mastocytosis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Cutaneous Mastocytosis Treatment Market Size by Country
10.4.1 Middle East & Africa Cutaneous Mastocytosis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cutaneous Mastocytosis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Cutaneous Mastocytosis Treatment Introduction
11.1.4 Novartis AG Revenue in Cutaneous Mastocytosis Treatment Business (2016-2021)
11.1.5 Novartis AG Recent Development
11.2 Mylan NV
11.2.1 Mylan NV Company Details
11.2.2 Mylan NV Business Overview
11.2.3 Mylan NV Cutaneous Mastocytosis Treatment Introduction
11.2.4 Mylan NV Revenue in Cutaneous Mastocytosis Treatment Business (2016-2021)
11.2.5 Mylan NV Recent Development
11.3 Teva Pharmaceutical Industries Ltd.
11.3.1 Teva Pharmaceutical Industries Ltd. Company Details
11.3.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.3.3 Teva Pharmaceutical Industries Ltd. Cutaneous Mastocytosis Treatment Introduction
11.3.4 Teva Pharmaceutical Industries Ltd. Revenue in Cutaneous Mastocytosis Treatment Business (2016-2021)
11.3.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.4 Bausch Health Companies Inc.
11.4.1 Bausch Health Companies Inc. Company Details
11.4.2 Bausch Health Companies Inc. Business Overview
11.4.3 Bausch Health Companies Inc. Cutaneous Mastocytosis Treatment Introduction
11.4.4 Bausch Health Companies Inc. Revenue in Cutaneous Mastocytosis Treatment Business (2016-2021)
11.4.5 Bausch Health Companies Inc. Recent Development
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Details
11.5.2 Pfizer Inc. Business Overview
11.5.3 Pfizer Inc. Cutaneous Mastocytosis Treatment Introduction
11.5.4 Pfizer Inc. Revenue in Cutaneous Mastocytosis Treatment Business (2016-2021)
11.5.5 Pfizer Inc. Recent Development
11.6 Teva Pharmaceutical Industries Ltd.
11.6.1 Teva Pharmaceutical Industries Ltd. Company Details
11.6.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.6.3 Teva Pharmaceutical Industries Ltd. Cutaneous Mastocytosis Treatment Introduction
11.6.4 Teva Pharmaceutical Industries Ltd. Revenue in Cutaneous Mastocytosis Treatment Business (2016-2021)
11.6.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.7 Sanofi S.A.
11.7.1 Sanofi S.A. Company Details
11.7.2 Sanofi S.A. Business Overview
11.7.3 Sanofi S.A. Cutaneous Mastocytosis Treatment Introduction
11.7.4 Sanofi S.A. Revenue in Cutaneous Mastocytosis Treatment Business (2016-2021)
11.7.5 Sanofi S.A. Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Cutaneous Mastocytosis Treatment Introduction
11.8.4 Johnson & Johnson Revenue in Cutaneous Mastocytosis Treatment Business (2016-2021)
11.8.5 Johnson & Johnson Recent Development
11.9 Bayer AG
11.9.1 Bayer AG Company Details
11.9.2 Bayer AG Business Overview
11.9.3 Bayer AG Cutaneous Mastocytosis Treatment Introduction
11.9.4 Bayer AG Revenue in Cutaneous Mastocytosis Treatment Business (2016-2021)
11.9.5 Bayer AG Recent Development
11.10 Mallinckrodt Pharmaceuticals
11.10.1 Mallinckrodt Pharmaceuticals Company Details
11.10.2 Mallinckrodt Pharmaceuticals Business Overview
11.10.3 Mallinckrodt Pharmaceuticals Cutaneous Mastocytosis Treatment Introduction
11.10.4 Mallinckrodt Pharmaceuticals Revenue in Cutaneous Mastocytosis Treatment Business (2016-2021)
11.10.5 Mallinckrodt Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cutaneous Mastocytosis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antihistamines
Table 3. Key Players of Corticosteroids
Table 4. Key Players of Mast Cell Stabilizers
Table 5. Key Players of Sympathomimetic Agents (Ephinephrine)
Table 6. Key Players of Photochemotherapy
Table 7. Global Cutaneous Mastocytosis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cutaneous Mastocytosis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Cutaneous Mastocytosis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Cutaneous Mastocytosis Treatment Market Share by Regions (2016-2021)
Table 11. Global Cutaneous Mastocytosis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Cutaneous Mastocytosis Treatment Market Share by Regions (2022-2027)
Table 13. Cutaneous Mastocytosis Treatment Market Trends
Table 14. Cutaneous Mastocytosis Treatment Market Drivers
Table 15. Cutaneous Mastocytosis Treatment Market Challenges
Table 16. Cutaneous Mastocytosis Treatment Market Restraints
Table 17. Global Cutaneous Mastocytosis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Cutaneous Mastocytosis Treatment Market Share by Players (2016-2021)
Table 19. Global Top Cutaneous Mastocytosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cutaneous Mastocytosis Treatment as of 2020)
Table 20. Ranking of Global Top Cutaneous Mastocytosis Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Cutaneous Mastocytosis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cutaneous Mastocytosis Treatment Product Solution and Service
Table 24. Date of Enter into Cutaneous Mastocytosis Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cutaneous Mastocytosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Cutaneous Mastocytosis Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Cutaneous Mastocytosis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Cutaneous Mastocytosis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Cutaneous Mastocytosis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Cutaneous Mastocytosis Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Cutaneous Mastocytosis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Cutaneous Mastocytosis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Cutaneous Mastocytosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Cutaneous Mastocytosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Cutaneous Mastocytosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Cutaneous Mastocytosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Cutaneous Mastocytosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Cutaneous Mastocytosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Cutaneous Mastocytosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Cutaneous Mastocytosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Cutaneous Mastocytosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Cutaneous Mastocytosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Cutaneous Mastocytosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Cutaneous Mastocytosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cutaneous Mastocytosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cutaneous Mastocytosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cutaneous Mastocytosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Cutaneous Mastocytosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Cutaneous Mastocytosis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Cutaneous Mastocytosis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Cutaneous Mastocytosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Cutaneous Mastocytosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Cutaneous Mastocytosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Cutaneous Mastocytosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Cutaneous Mastocytosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Cutaneous Mastocytosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cutaneous Mastocytosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cutaneous Mastocytosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cutaneous Mastocytosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Cutaneous Mastocytosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Cutaneous Mastocytosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Cutaneous Mastocytosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Novartis AG Company Details
Table 65. Novartis AG Business Overview
Table 66. Novartis AG Cutaneous Mastocytosis Treatment Product
Table 67. Novartis AG Revenue in Cutaneous Mastocytosis Treatment Business (2016-2021) & (US$ Million)
Table 68. Novartis AG Recent Development
Table 69. Mylan NV Company Details
Table 70. Mylan NV Business Overview
Table 71. Mylan NV Cutaneous Mastocytosis Treatment Product
Table 72. Mylan NV Revenue in Cutaneous Mastocytosis Treatment Business (2016-2021) & (US$ Million)
Table 73. Mylan NV Recent Development
Table 74. Teva Pharmaceutical Industries Ltd. Company Details
Table 75. Teva Pharmaceutical Industries Ltd. Business Overview
Table 76. Teva Pharmaceutical Industries Ltd. Cutaneous Mastocytosis Treatment Product
Table 77. Teva Pharmaceutical Industries Ltd. Revenue in Cutaneous Mastocytosis Treatment Business (2016-2021) & (US$ Million)
Table 78. Teva Pharmaceutical Industries Ltd. Recent Development
Table 79. Bausch Health Companies Inc. Company Details
Table 80. Bausch Health Companies Inc. Business Overview
Table 81. Bausch Health Companies Inc. Cutaneous Mastocytosis Treatment Product
Table 82. Bausch Health Companies Inc. Revenue in Cutaneous Mastocytosis Treatment Business (2016-2021) & (US$ Million)
Table 83. Bausch Health Companies Inc. Recent Development
Table 84. Pfizer Inc. Company Details
Table 85. Pfizer Inc. Business Overview
Table 86. Pfizer Inc. Cutaneous Mastocytosis Treatment Product
Table 87. Pfizer Inc. Revenue in Cutaneous Mastocytosis Treatment Business (2016-2021) & (US$ Million)
Table 88. Pfizer Inc. Recent Development
Table 89. Teva Pharmaceutical Industries Ltd. Company Details
Table 90. Teva Pharmaceutical Industries Ltd. Business Overview
Table 91. Teva Pharmaceutical Industries Ltd. Cutaneous Mastocytosis Treatment Product
Table 92. Teva Pharmaceutical Industries Ltd. Revenue in Cutaneous Mastocytosis Treatment Business (2016-2021) & (US$ Million)
Table 93. Teva Pharmaceutical Industries Ltd. Recent Development
Table 94. Sanofi S.A. Company Details
Table 95. Sanofi S.A. Business Overview
Table 96. Sanofi S.A. Cutaneous Mastocytosis Treatment Product
Table 97. Sanofi S.A. Revenue in Cutaneous Mastocytosis Treatment Business (2016-2021) & (US$ Million)
Table 98. Sanofi S.A. Recent Development
Table 99. Johnson & Johnson Company Details
Table 100. Johnson & Johnson Business Overview
Table 101. Johnson & Johnson Revenue in Cutaneous Mastocytosis Treatment Business (2016-2021) & (US$ Million)
Table 102. Johnson & Johnson Recent Development
Table 103. Bayer AG Company Details
Table 104. Bayer AG Business Overview
Table 105. Bayer AG Cutaneous Mastocytosis Treatment Product
Table 106. Bayer AG Revenue in Cutaneous Mastocytosis Treatment Business (2016-2021) & (US$ Million)
Table 107. Bayer AG Recent Development
Table 108. Mallinckrodt Pharmaceuticals Company Details
Table 109. Mallinckrodt Pharmaceuticals Business Overview
Table 110. Mallinckrodt Pharmaceuticals Cutaneous Mastocytosis Treatment Product
Table 111. Mallinckrodt Pharmaceuticals Revenue in Cutaneous Mastocytosis Treatment Business (2016-2021) & (US$ Million)
Table 112. Mallinckrodt Pharmaceuticals Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cutaneous Mastocytosis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Antihistamines Features
Figure 3. Corticosteroids Features
Figure 4. Mast Cell Stabilizers Features
Figure 5. Sympathomimetic Agents (Ephinephrine) Features
Figure 6. Photochemotherapy Features
Figure 7. Global Cutaneous Mastocytosis Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Cutaneous Mastocytosis Treatment Report Years Considered
Figure 12. Global Cutaneous Mastocytosis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Cutaneous Mastocytosis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Cutaneous Mastocytosis Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Cutaneous Mastocytosis Treatment Market Share by Regions (2022-2027)
Figure 16. Global Cutaneous Mastocytosis Treatment Market Share by Players in 2020
Figure 17. Global Top Cutaneous Mastocytosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cutaneous Mastocytosis Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Cutaneous Mastocytosis Treatment Revenue in 2020
Figure 19. Global Cutaneous Mastocytosis Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Cutaneous Mastocytosis Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Cutaneous Mastocytosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Cutaneous Mastocytosis Treatment Market Share by Type (2016-2027)
Figure 23. North America Cutaneous Mastocytosis Treatment Market Share by Application (2016-2027)
Figure 24. North America Cutaneous Mastocytosis Treatment Market Share by Country (2016-2027)
Figure 25. United States Cutaneous Mastocytosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Cutaneous Mastocytosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cutaneous Mastocytosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Cutaneous Mastocytosis Treatment Market Share by Type (2016-2027)
Figure 29. Europe Cutaneous Mastocytosis Treatment Market Share by Application (2016-2027)
Figure 30. Europe Cutaneous Mastocytosis Treatment Market Share by Country (2016-2027)
Figure 31. Germany Cutaneous Mastocytosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Cutaneous Mastocytosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Cutaneous Mastocytosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Cutaneous Mastocytosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Cutaneous Mastocytosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Cutaneous Mastocytosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cutaneous Mastocytosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Cutaneous Mastocytosis Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Cutaneous Mastocytosis Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Cutaneous Mastocytosis Treatment Market Share by Region (2016-2027)
Figure 41. China Cutaneous Mastocytosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Cutaneous Mastocytosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Cutaneous Mastocytosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Cutaneous Mastocytosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Cutaneous Mastocytosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Cutaneous Mastocytosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cutaneous Mastocytosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Cutaneous Mastocytosis Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Cutaneous Mastocytosis Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Cutaneous Mastocytosis Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Cutaneous Mastocytosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Cutaneous Mastocytosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cutaneous Mastocytosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Cutaneous Mastocytosis Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Cutaneous Mastocytosis Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Cutaneous Mastocytosis Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Cutaneous Mastocytosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Cutaneous Mastocytosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Cutaneous Mastocytosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Novartis AG Revenue Growth Rate in Cutaneous Mastocytosis Treatment Business (2016-2021)
Figure 61. Mylan NV Revenue Growth Rate in Cutaneous Mastocytosis Treatment Business (2016-2021)
Figure 62. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Cutaneous Mastocytosis Treatment Business (2016-2021)
Figure 63. Bausch Health Companies Inc. Revenue Growth Rate in Cutaneous Mastocytosis Treatment Business (2016-2021)
Figure 64. Pfizer Inc. Revenue Growth Rate in Cutaneous Mastocytosis Treatment Business (2016-2021)
Figure 65. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Cutaneous Mastocytosis Treatment Business (2016-2021)
Figure 66. Sanofi S.A. Revenue Growth Rate in Cutaneous Mastocytosis Treatment Business (2016-2021)
Figure 67. Johnson & Johnson Revenue Growth Rate in Cutaneous Mastocytosis Treatment Business (2016-2021)
Figure 68. Bayer AG Revenue Growth Rate in Cutaneous Mastocytosis Treatment Business (2016-2021)
Figure 69. Mallinckrodt Pharmaceuticals Revenue Growth Rate in Cutaneous Mastocytosis Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の皮膚B細胞リンパ腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous B-Cell Lymphoma Treatment Market The global Cutaneous B-Cell Lymphoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and hig…- 世界の皮膚扁平上皮がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous Squamous Cell Carcinoma Treatment Market The global Cutaneous Squamous Cell Carcinoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …
- 世界の皮膚T細胞リンパ腫（CTCL）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous T-Cell Lymphoma (CTCL) Treatment Market The global Cutaneous T-Cell Lymphoma (CTCL) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in an…
- 世界の皮膚細胞リンパ腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous Cell Lymphoma Treatment Market The global Cutaneous Cell Lymphoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high da…
- 世界の皮膚放射線障害治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous Radiation Injury Treatment Market The global Cutaneous Radiation Injury Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and h…